Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Company Overview - Genmab A/S is an international biotechnology company focused on improving the lives of patients through innovative antibody therapeutics [3][4] - Established in 1999 and headquartered in Copenhagen, Denmark, Genmab has a global presence in North America, Europe, and Asia Pacific [4] Business Strategy and Vision - The company aims to transform the lives of individuals with cancer and other serious diseases by 2030 through its proprietary pipeline of advanced antibody medicines [3] - Genmab's research includes next-generation antibody technology platforms, bispecific T-cell engagers, antibody-drug conjugates, and immune checkpoint modulators [3] Managerial Transactions - The managerial employees and their closely associated persons have authorized Genmab to publish their trading activities in Genmab shares [2][1]